BayCare Invested $33 Million in New Proton Center
The facility at St. Joseph's Hospital offers advanced radiation therapy using specialized upright seating for patients.
Updated on Oct. 14, 2026 in Healthcare
Live Poll
Should local hospitals prioritize investing in specialized cancer treatment facilities for their communities?
BayCare launched a new proton therapy center in Tampa, Florida, located at the Fred J. Woods Radiation Therapy Center within St. Joseph's Hospital. The facility began accepting patients on October 14, 2026, to expand access to precision radiation for regional residents.
Why it matters
This expansion brings localized access to targeted particle therapy to West Central Florida, reducing the need for patients to travel for specialized care. The inclusion of unique seating technology also allows for treatment of patients who cannot maintain a flat lying position during radiation.
BayCare committed $33 million to the new center, which stands as only the second facility worldwide to utilize specialized upright patient chair technology. The site integrates directly into the existing radiation oncology program at St. Joseph's Hospital.
The players
BayCare
A major healthcare network operating a broad system of hospitals, urgent care centers, and specialty clinics across West Central Florida.
Mevion Medical Systems
A developer of compact proton therapy platforms designed to integrate into existing hospital-based radiation oncology departments.
St. Joseph's Hospital
A key hospital facility in Tampa that serves as the host for the new specialized radiation oncology infrastructure.
The details
Proton therapy functions by using charged particles to deliver concentrated radiation to tumors while sparing surrounding healthy tissue from exposure. The facility utilizes a compact system from Mevion Medical Systems, which includes an upright chair designed to improve patient comfort and clinical access. By integrating this hardware into the existing Fred J. Woods Radiation Therapy Center, the facility streamlines specialized care delivery for oncology patients in the region.
Timeline
October 14, 2026: The BayCare Proton Center opened and began accepting patients.
Market Landscape
This facility follows the industry trend of decentralizing advanced proton therapy from large academic research hospitals into community-based hospital networks. It marks a significant shift in regional oncology capabilities by embedding high-end radiation assets into established care centers.
Operators in the healthcare space should monitor how the integration of compact particle therapy units affects patient referral patterns and oncology department revenue. Managers should assess whether local facility upgrades like this create new competitive pressures for outpatient imaging and radiation market share.
The takeaway
Investment in specialized oncology hardware can effectively differentiate regional healthcare networks by providing niche clinical capabilities. Administrators should evaluate the patient-volume requirements necessary to recoup high-capital medical equipment expenditures like this $33 million installation.
Further reading
For more on regional medical facility expansions, read our coverage of the Healthcare sector.
Source note: This article includes information reported by The Manila times.
Live Poll
Should local hospitals prioritize investing in specialized cancer treatment facilities for their communities?
